The Consortium for Clinical Research and Innovation, Singapore (CRIS) is pleased to announce the appointment of Prof Derek Hausenloy as Executive Director and A/Prof Mark Chan as Co-Director of its new National Clinical Translational Programme (NCTP) for cardiovascular diseases.

The CArdiovascular DiseasE National Collaborative Enterprise (CADENCE), is supported by the Singapore Ministry of Health’s National Medical Research Council under its CADENCE sub-initiative (NMRC/CADENCE/2023). CADENCE will be established as a business unit under CRIS.

Read more here: https://www.cris.sg/news-and-events/media-releases/cadence-appt/